Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatments for COPD.

Nicola A Hanania1, Nicolino Ambrosino, Peter Calverley

  • 1Pulmonary and Critical Care Medicine, Baylor College of Medicine, 1504 Taub Loop, Houston, TX 77030, USA. hanania@bcm.tmc.edu

Respiratory Medicine
|October 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rationale and Design of RECOVER-ENERGIZE: A Platform Clinical Trial of Interventions for Exercise Intolerance With and Without Post-exertional Malaise in Long COVID.

medRxiv : the preprint server for health sciences·2026
Same author

Developing a platform protocol for clinical trials evaluating interventions that target proposed mechanisms of Long COVID: RECOVER-VITAL.

Clinical trials (London, England)·2026
Same author

A CAPTURE ancillary study to assess GOLD 2025 spirometry recommendations in primary care adults.

Annals of the American Thoracic Society·2026
Same author

Frailty associates with respiratory exacerbations and mortality in the COPDGene cohort.

Aging·2025
Same author

Practical strategies for achieving system change in the US: lessons and insights from the CONQUEST quality improvement programme.

Primary health care research & development·2025
Same author

Post-COPD: Can Emphysema Be Repaired?

American journal of respiratory and critical care medicine·2025
Same journal

Impact of Therapeutic Hypothermia on Oxygen Demand and Respiratory Function in Post-Cardiac Arrest Patients: A Retrospective Cohort Study.

Respiratory medicine·2026
Same journal

The longitudinal decrease in exercise tolerance and disease progression in mild-to-moderate COPD.

Respiratory medicine·2026
Same journal

The implications of adopting the race-neutral spirometry equations in the detection of airway obstruction in Chilean children with asthma.

Respiratory medicine·2026
Same journal

Long-term outcomes of home mechanical ventilation in Duchenne Muscular Dystrophy - an observational study.

Respiratory medicine·2026
Same journal

CT-derived vascular parameters and bone mineral density in adults with cystic fibrosis.

Respiratory medicine·2026
Same journal

Effects of Integrated Inspiratory-Expiratory Muscle Training Within Hybrid Cardiac Rehabilitation Following Cardiac Surgery: A Randomized Controlled Study.

Respiratory medicine·2026
See all related articles

Treatments for chronic obstructive pulmonary disease (COPD) combine medications like bronchodilators and novel agents with non-pharmacological therapies. Future research will refine personalized COPD management strategies.

Area of Science:

  • Pulmonary Medicine
  • Pharmacology

Background:

  • Chronic obstructive pulmonary disease (COPD) presents complex challenges for effective treatment development.
  • Current management involves a combination of pharmacological and non-pharmacological strategies.

Purpose of the Study:

  • To provide an overview of current COPD treatments.
  • To discuss potential future directions in COPD pharmacotherapy and non-pharmacological interventions.
  • To highlight the need for precise evaluation of treatment efficacy and patient selection.

Main Methods:

  • Review of existing pharmacological treatments, including bronchodilators, inhaled corticosteroids, phosphodiesterase-4 inhibitors, and leukotriene B4 inhibitors.
  • Overview of non-pharmacological interventions such as long-term oxygen therapy (LTOT), nasal positive pressure ventilation (nPPV), pulmonary rehabilitation, and lung-volume-reduction surgery (LVRS).

Related Experiment Videos

Main Results:

  • Bronchodilators and inhaled corticosteroids are foundational pharmacological treatments.
  • New agents like phosphodiesterase-4 inhibitors are in advanced development.
  • Long-term oxygen therapy (LTOT) is the only intervention proven to improve survival in severe COPD, apart from smoking cessation.

Conclusions:

  • Future COPD treatment may involve novel pharmacotherapeutic agents and refined non-pharmacological approaches.
  • Further research is crucial to establish the precise value of different COPD treatments using clinical and physiological endpoints.
  • Developing tailored COPD management programs requires a deeper understanding of treatment efficacy and patient stratification.